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Breathing SPACE—a practical approach to the breathless
patient
Nicholas S. Hopkinson1 and Noel Baxter2 on behalf of the London Respiratory Network
Breathlessness is a common symptom that may have multiple causes in any one individual and causes that may change over time.
Breathlessness campaigns encourage people to see their General Practitioner if they are unduly breathless. Members of the London
Respiratory Network collaborated to develop a tool that would encourage a holistic approach to breathlessness, which was
applicable both at the time of diagnosis and during ongoing management. This has led to the development of the aide memoire
“Breathing SPACE”, which encompasses ﬁve key themes—smoking, pulmonary disease, anxiety/psychosocial factors, cardiac
disease, and exercise/ﬁtness. A particular concern was to ensure that high-value interventions (smoking cessation and exercise
interventions) are prioritised across the life-course and throughout the course of disease management. The approach is relevant
both to well people and in those with an underling diagnosis or diagnoses. The inclusion of anxiety draws attention to the
importance of mental health issues. Parity of esteem requires the physical health problems of people with mental illness to be
addressed. The SPACE mnemonic also addresses the problem of underdiagnosis of heart disease in people with lung disease and
vice versa, as well as the systematic undertreatment of these conditions where they do co-occur.
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INTRODUCTION
Breathlessness is one of the most common symptoms causing
people to interact with the health-care system, present in about
10% of all adults and 30% of older people.1,2 It can be frightening
and disabling, but many people ignore or normalise the symptom
and fail to act on it. This can delay diagnosis and effective
interventions, both medical and “lifestyle”. For example, data on
patients with chronic obstructive pulmonary disease (COPD) show
clearly that, for many individuals, opportunities are missed to
make a diagnosis in the years prior to the condition ﬁnally being
recognised.3,4 Multimorbidity is common5 and breathlessness in
any individual is likely to be multifactorial.6 The London
Respiratory Network wished to develop an aide memoire to
facilitate a systematic approach to this. Consensus discussions
identiﬁed smoking, pulmonary disease, anxiety, cardiac disease,
and exercise level/unﬁtness as important and often interacting
contributors to breathlessness, which can be encompassed by the
acronym “Breathing SPACE” (Table 1). These items should be
considered in any breathless patient, both during the diagnostic
process and their subsequent management, though they may not
all be addressed in a single consultation. The approach is intended
to be relevant both to health-care practitioners and to commis-
sioners of health-care services.
The application of this approach in two typical patients, one
with COPD and one where deconditioning is the main issue, is
illustrated in Fig. 1.
SMOKING
Smoking is a leading preventable cause of ill health, but smoking
cessation is also one of the most effective treatments for many
long-term conditions.11–14 Ask breathless patients about smoking
history, encourage smokers to quit and offer assistance to
overcome their tobacco dependence. Brief smoking cessation
advice is an effective intervention,15 but counselling support
combined with pharmacotherapy is more so.16 For example, the
cost per quality adjusted life year of combined smoking cessation
counselling and pharmacotherapy in COPD is only €2400,
compared with €8200 for intensive counselling and €16,900 for
brief advice.17 Providing evidence-based smoking cessation for
inpatients who smoke has been shown not only to signiﬁcantly
reduce readmissions at 30 days (by about half), but also to
signiﬁcantly reduce mortality at 1 year (again by about a half).13
Smoking is highly prevalent in socioeconomically deprived groups
and in those with mental health problems,18 and support to these
groups should be prioritised. The National Centre for Smoking
Cessation and Training website (www.ncsct.co.uk/) is a useful
resource, including online training.
PULMONARY DISEASE
Breathlessness is a characteristic manifestation of pulmonary
diseases such as COPD and asthma. Suggestive features may
trigger a referral, or investigations such as a chest X-ray. Perform
quality-assured spirometry promptly on any patient with symp-
toms of long-term breathlessness. This can be diagnostic for
airﬂow obstruction and the demonstration of abnormal lung
function provides an additional incentive for smokers to quit.19
Asthma is by deﬁnition variable so normal spirometry does not
rule it out. Timely diagnosis of COPD also has good value—low
diagnostic rates of COPD are associated with higher disease-
speciﬁc costs20 and prevalence of undiagnosed COPD is strongly
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associated with rates of hospital admission for acute exacerba-
tions.21 Prioritise high-value interventions, including ﬂu vaccina-
tion, smoking cessation, and pulmonary rehabilitation, which have
signiﬁcantly lower costs per QALY than pharmacotherapy
(Fig. 2).22
ANXIETY
Anxiety is taken here to represent a range of psychosocial
problems. Anxiety disorders can present with breathlessness as a
primary symptom. Alternatively, anxiety can aggravate the
symptoms of a long-term condition such as COPD or heart
failure.23–25 A key element of “parity of esteem” for mental health
is that the physical health problems of people with mental health
conditions are no longer neglected. Smoking rates are high in
people with mental illness and contribute considerably to reduced
life expectancy.18 Smoking cessation interventions are safe and
likely to be as effective in people with a mental health diagnosis as
those without.26–28
Pulmonary and cardiac rehabilitation improve mental as well as
physical components of health status.29,30 Although patients with
mental health problems beneﬁt from rehabilitation, they may be
less likely to attend or complete programmes31—identifying
people who need additional support and encouragement to
attend and continue rehabilitation is important. For some
individuals, participation in peer support activities like British
Lung Foundation Breathe Easy Groups may be beneﬁcial. Consider
referral for psychological therapy; cognitive-behavioural therapy is
efﬁcacious in people with respiratory disease and anxiety.32
CARDIAC CAUSES
A cardiac cause of breathlessness is suggested by a history of
hypertension, diabetes, hypercholesterolaemia or ischaemic heart
disease, and by physical ﬁndings such as lung crepitations, the
presenceofoedema, tachycardia, cardiacmurmurs,oratrialﬁbrillation.
A normal electrocardiogram (ECG) reduces the likelihood of cardiac
disease but consider investigations such as blood natriuretic peptide
(BNP) and echocardiography if there is clinical suspicion.33
Lung disease is also common in people with heart disease,5 so
the possibility of a dual diagnosis should be considered. For
example, 15–24% of people with COPD also have ischaemic heart
disease5 and one-third of people with atrial ﬁbrillation have a
diagnosis of asthma or COPD.34 Evidence suggests systematic
undertreatment of patients with COPD following myocardial
infarction; they are less likely to receive beta blockers, although
these can be safely administered.35
Hyperinﬂation caused by airﬂow obstruction restricts cardiac
output36 and the “cardiac” aspects of lung diagnoses should be
considered. In patients with COPD, low oxygen saturations,
especially if they are disproportionate to the degree of airﬂow
obstruction, may represent pulmonary hypertension that can lead
to right-sided heart failure. Consider sleep-disordered breathing
with nocturnal hypoxia in individuals with a high body mass index
(BMI), oedema, or a history of type II respiratory failure. Ask about
daytime somnolence, morning headaches, and confusion.
EXERCISE LEVEL AND FITNESS
Many people ﬁnd that their exercise capacity decreases as they
get older and attribute this to aging when it is in fact a
Table 1. The Breathing SPACE framework
Smoking cessation Ask about smoking, advise to quit, offer assistance to quit. Adopt the CO4 approach7:
1. The right COnversation, with every patient and staff member who smokes, that gives them a chance to quit, referring for
support if necessary
2. Offer routine exhaled carbon monoxide (CO) monitoring: “Would you like to know your level?”
3. COde smoking cessation interventions and include smoking history in death certiﬁcation
4. COmmission services where smoking cessation behaviours are incentivised systematically
Pulmonary disease Ask about symptoms—cough, sputum, variability, nocturnal symptoms, chest discomfort, haemoptysis
Investigations—rapid access to quality assured spirometry
Pulse oximetry
Prioritise high-value interventions—smoking cessation, pulmonary rehabilitation, ﬂu vaccination
Ensure that inhaled medications are both prescribed and used appropriately
Anxiety Psychosocial factors contribute to symptoms in cardiorespiratory disease. Anxiety may present with speciﬁc features of
hyperventilation/dysfunctional breathing syndrome, including paraesthesia and “air hunger”
Parity of esteem—address the physical health of people with mental health issues
Smoking cessation interventions are effective and safe to use in people with mental health problems
Peer support, e.g., BLF Breathe Easy groups
Cardiac disease Ask about risk factors (smoking, hypertension, diabetes, ischaemic heart disease?)
Abnormal pulse, pulmonary crepitations, oedema, cardiac murmurs
Cardiac complications of respiratory disease—pulmonary hypertension, sleep-disordered breathing
Investigations—consider ECG, BNP, echocardiogram
Refer patients with heart disease who feel limited by their symptoms for exercise rehabilitation
Exercise level and Ask about exercise level “Do you take any regular exercise?”
ﬁtness Give brief advice to increase physical activity levels8
Reassure and encourage: “It’s not harmful to make yourself breathless”
Refer patients with lung or heart disease who feel limited by their symptoms for exercise rehabilitation
Obesity—identify this explicitly as a contributor to breathlessness
Signpost opportunities to participate in exercise (e.g., Park Run, Couch to 5K). Pedometer-based interventions with a step count
goal are effective9,10
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consequence of physical inactivity and deconditioning.37 Exclud-
ing the presence of a speciﬁc pulmonary, cardiac, or psychological
pathology is likely to be the priority in a patient presenting with
breathlessness, but even having done this there is evidence that
brief interventions to increase physical activity in apparently
healthy people are cost-effective.8,38
People aging with a sedentary lifestyle are at increased risk of
developing many health conditions, including hypertension,
obesity, diabetes, depression, osteoporosis, frailty, and falls.
Adoption of walking and cycling, as well as improving the ﬁtness
of individuals and reducing their risk of future disease, also has
other beneﬁts.39 It reduces the emission of pollutants (particulates,
NO2), which increase the risk of developing conditions like asthma
and worsen outcomes in people who already have cardiorespira-
tory disease. The reduction in carbon emissions from adopting
active transport also brings a climate change beneﬁt.
Fig. 1 Application of Breathing SPACE in a typical patient with COPD (a) and in a patient where the main issue is deconditioning and lifestyle
(b). In a typical patient with COPD, all ﬁve of the SPACE elements may be in play with attention required to Smoking cessation, treatments
directly for the Pulmonary condition (vaccination, rehabilitation, inhaled medication), Anxiety about going outside for fear of being seen to be
breathless, ensuring medication for a Cardiac co-morbidity is optimised, and a need to continue to consider increase Exercise levels following
pulmonary rehabilitation and behaviour change
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Fig. 2 The pyramid of value for COPD interventions.The pyramid of value for COPD interventions developed by the London Respiratory
Network with The London School of Economics (reproduced from22) gives estimates of cost per quality-adjusted life year gained. LABA long-
acting β2 agonist, QALY quality-adjusted life year
Table 2. Breathing SPACE—challenges for commissioners of health and social care
Invest in a population-based approach, describing aims, objectives, and criteria to evaluate the impact of a breathlessness system. Adapt and
develop local provision to reduce waste and increase value: know your neighbourhood and local services (tobacco dependence, obesity and
physical activity services will vary considerably in the United Kingdom and internationally).
1. Deﬁne the scope of the breathlessness system.
2. Deﬁne the population to be served, which may include sub-populations or segments at different levels of complexity and activation requiring
different services. It may include people with complex needs, such as homeless people, who are known to many service providers, including
General Practitioner, ambulance services, emergency departments, and respiratory departments, who would beneﬁt from better care coordination
to improve their breathlessness.
3. Reach agreement on the aim and objectives of the services provided by the system, also considering options for disinvestment.
4. For each objective, agree one or more criteria by which the performance of the service would be assessed.
5. For each of the criteria, identify levels of performance that can be used as quality standards, based on the data locally available.
6. Identify all the resources used in the system, thus creating a breathlessness budget, including clinical staff, equipment, diagnostic tests, hospital
beds, prescribing budgets, estates, and administration.
7. Identify who needs to be engaged in a clinical network that will provide collective leadership for the system and be accountable for its
performance.
8. Produce a breathlessness system speciﬁcation, which can be used for contractual arrangements between providers and payers.
9. Agree upon an evaluation framework to assess the impact of the breathlessness system.
Commission smoking cessation services—local authority and clinical commissioners should work together to consider where smoking cessation
services will have the greatest impact on their joint outcome measures. These are extremely of high value compared with other health
interventions and must be protected.
Nine million people still smoke in the United Kingdom—increasingly concentrated in harder to reach groups. Incorporate smoking cessation into
care pathways for mental health services, people admitted to hospital, and the homeless.
Commission pathways for breathlessness diagnostics that can address both cardiac and respiratory causes from general practice to specialist
units. The IMPRESS decision support tool provides an outline of the key decision-making processes in these clinical encounters (https://www.
networks.nhs.uk/nhs-networks/impress-improving-and-integrating-respiratory/news/impress-breathlessness-resources)
Systems should address the under-diagnosis and treatment of cardiac disease in people with respiratory diagnoses, and the under-diagnosis and
treatment of respiratory disease in people with cardiac diagnoses
Ensure that palliative care services are also available for patients with breathlessness due to non-malignant conditions
Parity of esteem—health systems need to address physical conditions in people with mental health problems
Commission pulmonary rehabilitation, as this is an extremely high-value intervention compared with other health interventions.
Attention to breathlessness in midlife has the potential to reduce sedentarism and the accumulation of multi-morbidities.
Breathing SPACE
NS Hopkinson and N Baxter
4
npj Primary Care Respiratory Medicine (2017)  5 Published in partnership with Primary Care Respiratory Society UK
Exercise rehabilitation is known to be an effective intervention
in cardiorespiratory disease29,40–42 and pulmonary rehabilitation is
one of the highest value interventions in COPD.22 Of note, activity
levels are reduced even in early COPD43 and inactivity is
associated with more rapid decline in lung function in healthy
populations and with more rapid progression of COPD.44 Although
it has not been subjected to prospective randomised controlled
trials, these observations do suggest that, in people diagnosed at
an early stage, robust encouragement to increase activity level
with a clear explanation of the beneﬁts of doing so may alter the
way that their lung condition progresses as they age. Of equal
importance, increasing physical activity should also limit the
development and impact of multi-morbidities—including hyper-
tension, diabetes, osteoporosis, depression, and cognitive dys-
function—that are known to accumulate through the impact of
progressive sedentarism.45 A person who understands the need to
push against the limits of their breathlessness as part of their self-
management of a long-term condition, and believes in their
capacity to do so, could be expected to maintain their
performance better than someone who is slowly withdrawing
from activities in the face of unexplained breathlessness due to
progressive, undiagnosed, cardiorespiratory disease. A key mes-
sage for patients is that it is not harmful to make yourself
breathless. Pedometer-based interventions with a step count goal
are effective.9,10
A COORDINATED APPROACH—MULTIMORBIDITY
Multimorbidity is the norm rather than the exception; only 20% of
people with COPD have it as their only long-term condition.5
Exercise and smoking cessation will beneﬁt other conditions such
as hypertension and diabetes, as well as cardiac and pulmonary
disease. Anaemia may present with breathlessness and is
potentially reversible. Where a referral is made it should ideally
be to a service that can function in a way that is symptom speciﬁc,
dealing with “breathlessness”, rather than to one that can only
investigate from a cardiac or respiratory perspective with the
patient requiring a second referral if one or other condition is
excluded. Table 2 includes recommendations for commissioners,
and further recommendations are available in this European
Respiratory Society Monograph.46
CONCLUSION
Breathlessness is an important and challenging symptom. The
Breathing SPACE approach should help to ensure that underlying
diagnoses will not be missed, especially if there is more than one,
and also that these are considered as patients are followed up
over time. Focus attention on high-value interventions, in
particular smoking cessation and exercise rehabilitation, to
optimise the sustainable and equitable utilisation of ﬁnite
health-care resources.
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